Activation of Neuronal Gene Expression by the JMJD3 Demethylase Is Required for Postnatal and Adult Brain Neurogenesis by D.H. Park et al.
Cell Reports
ReportActivation of Neuronal Gene Expression
by the JMJD3 Demethylase Is Required
for Postnatal and Adult Brain Neurogenesis
Dae Hwi Park,1,2,3 Sung Jun Hong,1,2 Ryan D. Salinas,1,2 Siyuan John Liu,1,2 Shawn W. Sun,1,2,3 Jacopo Sgualdino,4
Giuseppe Testa,4 Martin M. Matzuk,5,6,7,8,9,10 Naoki Iwamori,5,9,11 and Daniel A. Lim1,2,3,*
1Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94143, USA
2Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco,
CA 94143, USA
3Veterans Affairs Medical Center, University of California, San Francisco, San Francisco, CA 94143, USA
4European Institute of Oncology (IEO), IFOM-IEO Campus, Via Adamello 16, 20139 Milan, Italy
5Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA
6Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA
7Department of Molecular Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
8Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030, USA
9Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX 77030, USA
10Center for Drug Discovery, Baylor College of Medicine, Houston, TX 77030, USA
11Center of Biomedical Research, Research Center for Human Disease Modeling, Graduate School of Medical Sciences, Kyushu University,
Fukuoka 812-8582, Japan
*Correspondence: limd@neurosurg.ucsf.edu
http://dx.doi.org/10.1016/j.celrep.2014.07.060
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).SUMMARY
The epigenetic mechanisms that enable lifelong neu-
rogenesis from neural stem cells (NSCs) in the adult
mammalian brain are poorly understood. Here, we
show that JMJD3, a histone H3 lysine 27 (H3K27)
demethylase, acts as a critical activator of neurogen-
esis from adult subventricular zone (SVZ) NSCs.
JMJD3 is upregulated in neuroblasts, and Jmjd3
deletion targeted to SVZ NSCs in both developing
and adult mice impairs neuronal differentiation.
JMJD3 regulates neurogenic gene expression via
interaction at not only promoter regions but also
neurogenic enhancer elements. JMJD3 localizes at
neural enhancers genome-wide in embryonic brain,
and in SVZ NSCs, JMJD3 regulates the I12b
enhancer of Dlx2. In Jmjd3-deleted SVZ cells, I12b
remains enriched with H3K27me3 and Dlx2-depen-
dent neurogenesis fails. These findings support a
model in which JMJD3 and the poised state of key
transcriptional regulatory elements comprise an
epigenetic mechanism that enables the activation
of neurogenic gene expression in adult NSCs
throughout life.
INTRODUCTION
Epigenetic regulation via histone methylation is critical for
the establishment and maintenance of lineage-specific gene
expression. The trimethylation of histone 3 at lysine 271290 Cell Reports 8, 1290–1299, September 11, 2014 ª2014 The Au(H3K27me3) by Polycomb repressive complex 2 (PRC2) corre-
lates with transcriptional repression (Margueron and Reinberg,
2011), and such gene repression is critical for the proper function
of stem cells in both the embryonic and adult brain (Hirabayashi
and Gotoh, 2010). While previous studies have highlighted the
importance of H3K27me3 placement and gene repression in
neural development (Hirabayashi et al., 2009; Hwang et al.,
2014; Pereira et al., 2010), how H3K27me3 is removed for the
activation of neurogenic gene expression is not well understood.
JMJD3 (KDM6B) is an H3K27me3-specific demethylase that
belongs to the family of JmjC domain-containing proteins (Agger
et al., 2007; De Santa et al., 2007). Jmjd3 null mice die at birth
due to respiratory failure (Burgold et al., 2012; Satoh et al.,
2010). In the embryonic mouse forebrain, Jmjd3 expression is
regulated (Jepsen et al., 2007), and in embryonic stem cells
(ESCs), JMJD3 is required for neural commitment (Burgold
et al., 2008). While knockdown studies in the embryonic spinal
cord and retina indicate developmental roles for Jmjd3 (Akizu
et al., 2010; Iida et al., 2014), the function of JMJD3 in adult neu-
ral stem cells (NSCs) has not been reported.
The adult mammalian brain harbors NSCs in the subventricular
zone (SVZ) and dentate gyrus of the hippocampus (Fuentealba
et al., 2012; Ming and Song, 2011). The epigenetic mechanisms
required to maintain lifelong neurogenesis in these germinal
zones are only beginning to be elucidated (Gonzales-Roybal
and Lim, 2013; Ma et al., 2010). Emerging evidence indicates
that dynamic changes of chromatin modifications at transcrip-
tional enhancers are a strong determinant of gene expression
(Calo and Wysocka, 2013). Like promoters, the activity of
enhancers can be ‘‘poised’’ by the presence of repressive
H3K27me3 (Rada-Iglesias et al., 2011), suggesting that tran-
scription can be activated by the action of H3K27me3-specificthors
demethylases at enhancer regions. Our data support a model in
which adult NSCs maintain a distinct set of transcriptional regu-
latory elements in a poised chromatin state, and that JMJD3 can
rapidly activate lineage-specific gene expression via H3K27 de-
methylation at specific genomic regions including enhancers.
RESULTS
JMJD3 Is Expressed in the Adult SVZ Neurogenic
Lineage
Throughout adult life, SVZ NSCs (type B1 cells) produce transit-
amplifying cells (type C cells), which give rise to neuroblasts
(type A cells) that migrate to the olfactory bulb (OB), where they
become interneurons (Figures S1A and S1B). RNA sequencing
(RNA-seq) and in situ hybridization analysis revealed prominent
Jmjd3 expression in the SVZ, the neuroblast rostral migratory
stream (RMS), and OB (Figures S1C and S1D) (Lein et al., 2007).
SVZ NSCs express glial fibrillary acidic protein (GFAP), and
many (79.5%, n = 30/38) GFAP+ SVZ cells exhibited nuclear
JMJD3 (Figure S1E). Transit-amplifying cells and neuroblasts ex-
press DLX2, and most (97.6%, n = 280/287) DLX2+ cells coex-
pressed JMJD3 (Figures S1F and S1I). JMJD3 was also present
in doublecortin (DCX)+ neuroblasts (Figure S1G). Thus, JMJD3 is
expressed SVZ NSCs as well as their neurogenic daughter cells.
JMJD3 Is Required for Postnatal OB Neurogenesis
To study the role of JMJD3 in SVZ-OB neurogenesis, we used a
conditional knockout allele of Jmjd3 (Jmjd3F/F, Figures S2A–
S2C). Mice with the hGFAP-Cre transgene exhibit excision of
conditional alleles in SVZ NSC precursors at embryonic day
13.5 (E13.5) (Lim et al., 2009), and SVZ cells of hGFAP-
Cre;Jmjd3F/F mice were JMJD3 negative (Figure S1J). hGFAP-
Cre;Jmjd3F/F mice and their littermate controls (wild-type and
hGFAP-Cre;Jmjd3F/+) were born at the expected Mendelian
ratios and were similar in size, weight, and overall survival.
To assess OB neurogenesis, we injected postnatal day 30
(P30) mice with 5-bromo-2-deoxyuridine (BrdU) to label a cohort
of newly born SVZ neuroblasts and analyzed the OB for BrdU+
neurons 10 days later. In the hGFAP-Cre;Jmjd3F/F OBs, there
were approximately 50% fewer BrdU+, NeuN+ neurons (Figures
1A–1C), which was not likely related to changes in neuronal sur-
vival, as the number of activated caspase-3+ OB cells was not
increased (Figure 1D).
To evaluate the production of neuroblasts in the SVZ, we
administered the thymidine analog ethynyl deoxyuridine (EdU)
to mice 1 hr before being culled. In P40 hGFAP-Cre;Jmjd3F/F
mice, there were 2- to 3-fold fewer DCX+, EdU+ cells in the
SVZ (Figures 1H–1I). Furthermore, the expression of DLX2, a
key neurogenic transcription factor, was strongly reduced (Fig-
ures 1K and 1K0). Despite there being fewer EdU+ cells in
hGFAP-Cre;Jmjd3F/F mice, the dorsal SVZ was abnormally
expanded with DCX+ cells (Figures 1F–1G0 and S2D–S2F0).
Defective neuroblast migration can result in the postnatal accu-
mulation of DCX+ cells in the SVZ (Lim et al., 2009); in hGFAP-
Cre;Jmjd3F/F mice, the neuroblast migratory pathways were
highly disorganized (Figures S2K and S2K0), and many SVZ cells
pulse-labeled with BrdU failed to migrate from the SVZ (Figures
S2G–S2I0). Thus, in hGFAP-Cre;Jmjd3F/F mice, the addition ofCell Renew neurons to theOBwas abrogated by a decrease in SVZ neu-
rogenesis as well as abnormal neuroblast migration.
Adult SVZ NSCs (type B1 cells) contact the ventricle with a
specialized apical surface located at the center of a pinwheel-
like structure composed of ependymal cells (Mirzadeh et al.,
2008). Interestingly, adult hGFAP-Cre;Jmjd3F/F mice had 3- to
4-fold more SVZ cells with such ventricular contact (Figures
S2M–S2O). As is characteristic of type B1 cells, these apical sur-
faces had solitary basal bodies and were GFAP+ (Figures S2P–
S2S0). This accumulation of type B1-like cells was evident by
P7 (Figures S3A–S3L0) and not likely related to cell proliferation
(Figures S3M–S3R0). Thus, although hGFAP-Cre;Jmjd3F/F mice
had greater numbers of cells with SVZ NSC characteristics, the
production of neuroblasts was reduced, suggesting that the
ventricle-contacting SVZ cells in hGFAP-Cre;Jmjd3F/F mice are
defective for neurogenesis.
Jmjd3 Deletion Targeted to Adult SVZ NSCs Inhibits OB
Neurogenesis
To test whether Jmjd3 plays a role in adult neurogenesis
independent of its potential function in postnatal SVZNSCdevel-
opment, we targeted Jmjd3-deletion to SVZ NSCs in adult
mice (Figures 1L–1M0). Stereotactic injection of the Ad:GFAP-
Cre adenovirus into the SVZ induces Cre-mediated recom-
bination in GFAP+ NSCs (Mirzadeh et al., 2008). We injected
Ad:GFAP-Cre into the SVZ of P60-90 Jmjd3F/F mice or littermate
controls (Jmjd3F/+) that carry the Ai14-tdTomato Cre-reporter
transgene. To control for experimental variation related to the
stereotactic injection itself, the Ad:GFAP-Cre adenovirus was
mixed and coinjected with a lentivirus that constitutively ex-
presses only GFP (lenti-GFP).
We quantified the number of tdTomato+ OB neurons in
Jmjd3F/F;Ai14 and control;Ai14 mice 14 days after injection (Fig-
ures 1N–1P). For each mouse, the number of tdTomato+ OB
neurons was normalized to the number of GFP+ OB neurons.
In control;Ai14 mice, there were 5.5 tdTomato+ cells per 10
GFP+ cells in the OB. In contrast, there were only 2.0 tdTomato+
cells per 10 GFP+ cells in the OB of Jmjd3F/F;Ai14 mice. Thus,
Jmjd3-deleted SVZ NSCs produced 60% fewer OB neurons
than NSCs in control mice. Furthermore, in the SVZ of Jmjd3F/F
mice, there were 24% fewer DLX2+, tdTomato+ cells (Figures
S2T–S2W). Taken together, these results indicate that adult
NSCs require Jmjd3 for SVZ-OB neurogenesis.
Jmjd3 Regulates the Differentiation of SVZ NSCs
We next used SVZ NSCs monolayer cultures to study JMJD3
function. During differentiation, SVZ NSCs upregulated Jmjd3,
correlating with increased Dlx2 expression (Figures S4A–S4G).
Short-hairpin RNA (shRNA) Jmjd3-knockdown lentiviruses (LV-
KD1-GFP and LV-KD2-GFP) strongly reduced Jmjd3. Jmjd3
knockdown reduced Dlx2 expression, but not the expression
of proneural Mash1, PRC2 component Ezh2, or Utx (Kdm6a),
the other known H3K27me3-specific demethylase (Figures 2A
and 2B).
To target shRNA knockdown to GFAP+ SVZ NSCs, we used
an EnvA-pseudotyped lentivirus and tva receptor transgenic
mouse strategy (Holland et al., 1998; Lewis et al., 2001)
(Figure 2A). In self-renewal conditions, Jmjd3 knockdown inports 8, 1290–1299, September 11, 2014 ª2014 The Authors 1291
Figure 1. Jmjd3 Is Required for Adult OB Neurogenesis
(A) Illustration of the experimental design for (B)–(D). The blue box indicates regions of shown in (B) and (B0). GCL, granule cell layer.
(B) Analysis of OB neurogenesis. Immunohistochemistry (IHC) for BrdU (green) and NeuN (red) in coronal OB sections of control (B) and hGFAP-Cre;Jmjd3F/F
mice (B0).
(C) Quantification of BrdU+, NeuN+ OB neurons (***p < 0.001; n = 4 each; error bars represent SEM).
(D) Quantification of cleaved caspase-3+ OB cells (p = 0.1933; n = 4 each; error bars represent SEM)
(E) Illustration of the experimental design for (F)–(I). EdU was injected 1 hr before analysis.
(F–I) Analysis of cell proliferation and neuroblasts in the SVZ.
(F–H) DAPI+ (white), DCX+ (green), and EdU+ (white) cells in the SVZ of control mice. (F0–H0 ) DAPI+ (white), DCX+ (green), and EdU+ (white) cells in the SVZ of
hGFAP-Cre;Jmjd3F/F mice.
(I) Quantification of EdU+, DCX+ cells in SVZ coronal sections (n = 3 each; error bars represent SEM; **p < 0.01).
(J–K0 ) Analysis of DLX2 expression in the SVZ. IHC for DLX2 (red) in SVZ coronal sections of control (J–K) and hGFAP-Cre;Jmjd3F/F mice (J0–K0). (K) and (K0) are
higher-magnification views of the yellow boxed region in (J) and (J0).
(L) Schematic illustration of the experimental design for (M)–(P). Ad:GFAP-Cre virus (to delete floxed alleles in GFAP+ SVZ NSCs) and GFP lentivirus (injection
control) were coinjected into the adult SVZ of tdTomato;Jmjd3F+ (M–O) or tdTomato;Jmjd3FF (M0–O0) mice.
(M–P) Analysis of OB neurogenesis. IHC for GFP (green) and tdTomato (red) in adult SVZ coronal sections of tdTomato;Jmjd3F+ (M) and tdTomato;Jmjd3FF
mice (M0 ).
(N–O0) IHC forGFP (green) and tdTomato (red) in coronalOBsections of tdTomato;Jmjd3F+ (N andO) and tdTomato;Jmjd3FFmice (N0 andO0) 14 days after injection.
(P) Quantification of tdTomato+ neurons per ten GFP+ neurons in the OB (****p < 0.0001; n = 4 per group; error bars represent SEM). LV, lateral ventricle;
Str, striatum; GCL, granule cell layer.
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Figure 2. Jmjd3 Regulates SVZ NSC Differentiation
(A) EnvA and hGFAPp-tva strategy of targeting knockdown to GFAP+ SVZ
NSCs. EnvA (red) pseudotyped lentiviruses can only infect cells with the tva
receptor (blue), which is expressed from the GFAP-tva transgene.
(B) Quantitative RT-PCR (qRT-PCR) analysis of LV-Jmjd3 knockdown in SVZ
NSCs (error bars represent SEM).
(C) Illustration of the experimental design for (D)–(G).
(D) ICC for GFP (green) and DLX2 (red) with LV-sh-Jmjd3 (D) and LV-sh-
luciferase (D0).
(E) Quantification of DLX2+ cells.
Cell ReGFAP+ SVZ NSCs did not affect BrdU incorporation or cell
viability and the expression of NSC marker Sox2 and cell-cycle
inhibitor p16was unaffected, suggesting that NSCs self-renewal
was not impaired (Figures S4H, S4I, and S4M). After 2 days of
differentiation, there were approximately 50% fewer DLX2+ cells
with Jmjd3 knockdown, and the production of Tuj1+ neurons
after 4 days was reduced by nearly 5-fold (Figures 2C–2G).While
Jmjd3 knockdown did not reduce the number of GFAP+ astro-
cytes, the production of OLIG2+ cells andO4+ oligodendrocytes
was impaired (Figures S4J–S4L). Thus, Jmjd3 is required for
proper SVZ NSC differentiation.
The cis-regulatory regions of Jmjd3 harbor retinoic acid (RA)
receptor response elements (Jepsen et al., 2007), and RA regu-
lates postnatal SVZ neurogenesis in vivo (Wang et al., 2005). The
addition of RA to SVZ NSCs increased Jmjd3 expression by 2- to
3-fold, and Dlx2 was also induced 8- to 9-fold (Figure 2H).
Furthermore, transient transfection of a Jmjd3 expression vec-
tor, but not a construct in which the catalytic JmjC domain is in-
activated (Jmjd3-Mut) (Burgold et al., 2008), increased the
expression of both Dcx and Dlx2 (Figure 2I). Thus, in SVZ
NSCs, Jmjd3 can be upregulated by RA, and increased levels
of Jmjd3 induce neurogenic gene expression.
Dlx2 Overexpression Rescues Neurogenesis from
Jmjd3-Deficient SVZ NSCs
To investigate whether Dlx2 is a key developmental factor for
Jmjd3-dependent neurogenesis, we enforced Dlx2 expression
in Jmjd3-deficient SVZ cells. GFAPp-tva SVZ cultures were first
infected with LV(EnvA)-shRNA-GFP constructs. After 2 days,
cultures were infected with lentiviruses that express Dlx2 (LV-
Dlx2-dsRed) or control (LV-AP-dsRed) (Figure 2J). Remarkably,
LV-Dlx2-dsRed rescued neuronal differentiation from Jmjd3-
deficient cells (Figures 2K–2M). Furthermore, injection of LV-
Dlx2-GFP into the SVZ hGFAP-Cre;Jmjd3F/F mice increased
the number of DCX+ cells (Figures S4N–S4R). Taken together,
these results suggest that the activation of Dlx2 is a key aspect
of Jmjd3-dependent neurogenesis.
JMJD3 Is Required for Removal of H3K27me3 at Key
Transcriptional Promoters in SVZ NSCs
To gain broader insight into Jmjd3-dependent gene expres-
sion, we performed microarray analysis. Treatment of SVZ(F) ICC for GFP (green) and Tuj1 (red) with LV-sh-Jmjd3 (F) and LV-sh-
luciferase (F0).
(G) Quantification of Tuj1+ cells (error bars represent SEM of quadruplicate
cultures; *p < 0.05, ***p < 0.001).
(H) qRT-PCR analysis of retinoic acid treatment of SVZ NSCs (***p < 0.001;
*p < 0.05; n = 6 per group; error bars represent SEM).
(I) qRT-PCR analysis of Jmjd3 overexpression in SVZ NSCs (**p < 0.01,
*p < 0.05; n = 3; error bars represent SEM).
(J) Illustration of the experimental design for (K) –(M).
(K–M) Analysis of neuronal differentiation in Jmjd3-deficient cells after Dlx2
overexpression.
(K–L0) IHC for Tuj1 (white) in Jmjd3-deficient cells with Dlx2 overexpression
(yellow in K0, corresponding white cells in L0) and control vector expression
(yellow in K, corresponding white cells in L).
(M) Quantification of Dlx2 rescue of neurogenesis (error bars represent SEM of
quadruplicate cultures; **p < 0.01).
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Figure 3. JMJD3 Is Required for H3K27me3 Demethylation at Neural Gene Promoters in SVZ NSCs
(A and B) ICC for Tuj1 (red) in SVZ NSC cultures from P8 UBC-Cre/ERT2;Jmjd3F/F mice after 4 days of differentiation. Jmjd3 was deleted in SVZ NSCs by 50 nM
4-OHT treatment.
(C) Top: schematic of microarray analysis of SVZ cell differentiation and differential expression between Jmjd3-deleted and control cells. Bottom left: Venn
diagram depicting overlap between normal gene upregulation and Jmjd3-dependent upregulation; 18 genes in the overlap are listed.
(D) H3K4me3 and H3K27me3 ChIP-seq enrichment tracks at the Gjb6 locus from undifferentiated NSC cultures. H3K27me3 is enriched at the Gjb6 promoter
located at the right.
(E) Heatmap of gene expression profile for Myt1, Slc32a1, and Gjb6.
(F and F0) qChIP analysis of H3K27me3 in control (EtOH) and Jmjd3-deleted cells (4OHT) atMyt1, Slc32a1, andGjb6 promoters. White bars correspond to control
cells. Hatched bars correspond to Jmjd3-deleted cells. ***p < 0.001, **p < 0.01 in comparison to proliferating cells.
(G) qChIP analysis of JMJD3 atMyt1, Slc32a1, and Gjb6 promoters in differentiating NSCs. ***p < 0.001, **p < 0.01 compared to immunoglobulin G. Error bars
represent SD; n = 3. undiff, undifferentiated SVZ NSCs; +diff, differentiated SVZ cells.NSCs from UBC-Cre/ERT2;Jmjd3F/F mice with 4-OHT resulted
in Jmjd3 deletion, and neurogenesis was severely impaired
(Figures 3A, 3B, and S5A). In nondeleted cultures, 1,050 genes
were upregulated after 30 hr of differentiation (>1.5-fold; false
discovery rate [FDR]-corrected p value < 0.05; n = 3). In differ-
entiating Jmjd3-deleted cells, 18 of these genes, including1294 Cell Reports 8, 1290–1299, September 11, 2014 ª2014 The AuDlx2, failed to reach the same levels of expression (>1.5-fold
decreased as compared to control cells; FDR-corrected
p value < 0.05; n = 3; Figure 3C). Analysis of chromatin immu-
noprecipitation sequencing (ChIP-seq) data (Ramos et al.,
2013) indicated that 12 of the 18 genes were enriched
for H3K27me3 in undifferentiated SVZ NSCs (Figure 3D),thors
Figure 4. JMJD3 Is Enriched at Neural Transcriptional Enhancers
(A) JMJD3 and p300 enrichment across 4,425 neural enhancers and their flanking regions.
(B) The top eight enriched Gene Ontology terms identified with GREAT analysis for the 2,611 JMJD3 and p300 enriched enhancers.
(C) Averaged enrichment profile of JMJD3 and p300 across 4,425 putative neural enhancers and their flanking regions.suggesting that removal of this repressive mark is required for
their upregulation.
In differentiating SVZ cells, the increased expression of
Myt1, Slc32a1, and Gjb6—genes involved in neurogenesis—
was strongly Jmjd3 dependent (Figure 3E). In undifferentiated
NSCs, these gene promoters were enriched for H3K27me3,
and in control cells, H3K27me3 levels were reduced during dif-
ferentiation (Figure 3F), and JMJD3 protein was detected at
these promoters (Figure 3G). In contrast, in Jmjd3-deleted cells,
H3K27me3 levels were not decreased with differentiation (Fig-
ure 3F0). Thus, JMJD3 is required for H3K27 demethylation at
specific gene promoters during SVZ NSC differentiation.
The promoter region upstream of the Dlx2 transcriptional start
site (TSS) contains regulatory elements (Ghanem et al., 2012).
Interestingly, in undifferentiated SVZ NSCs, the TSS and prox-
imal promoter was not enriched with H3K27me3 (Figure S5B).
Furthermore, this low level of H3K27me3 did not change during
differentiation, indicating that H3K27me3 levels at the promoter
do not correlate with Dlx2 upregulation.
JMJD3 Is Enriched at Neural Transcriptional Enhancers
Some transcriptional enhancers in stem cells exist in a poised
state, which includes H3K27me3 enrichment. To investigate
whether JMJD3 localizes at enhancers in neural development,
we analyzed JMJD3 ChIP-seq data from NSCs derived from
E12.5 mouse cortex (Estara´s et al., 2012) in conjunction with
p300 localization in E11.5 cortex (Visel et al., 2013). Of the
4,425 potential enhancer regions bound by p300, 2,611 (59%)
exhibited JMJD3 enrichment (Figures 4A and 4C). TheseCell ReJMJD3-enriched enhancers correlated with brain development
(McLean et al., 2010), including differentiation toward neuronal
lineages (Figure 4B). Together, these data suggest that JMJD3
can regulate the chromatin state of neural-specific enhancers
genome-wide. We therefore hypothesized that JMJD3 regulates
Dlx2 expression in SVZ NSCs through interactions at a key
enhancer.
JMJD3 Is Required for H3K27me3 Demethylation of a
Dlx2 Enhancer
I12b is an enhancer that regulates the expression ofDlx2 (Poitras
et al., 2007) (Figure 5A). In SVZ NSC cultures, I12b had a poised
chromatin state, which included high levels of H3K27me3 (Fig-
ures S5C and S5D). To analyze I12b chromatin state changes
in the SVZ neurogenic lineage, we used fluorescence-activated
cell sorting (FACS) to isolate GFAP+, NESTIN+ SVZ NSCs in
self-renewal conditions and Tuj1+ neuroblasts 3 days after dif-
ferentiation (Figures 5B–5E). In NSCs, I12b was enriched with
H3K27me3. In the neuroblasts, H3K27me3 was decreased
12-fold (Figure 5C). This reduction in H3K27me3 correlated
with JMJD3 enrichment at I12b (Figure 5D). Furthermore, in neu-
roblasts, H3K27 acetylation (H3K27ac) was increased (Fig-
ure 5E). Thus, JMJD3 enrichment at I12b correlated with the
chromatin state activation of this Dlx2 enhancer. Another
Dlx1/2 enhancer, URE2, had lower levels of H3K27me3 that
did not decrease during neuronal differentiation (Figures S5C
and S5E). We therefore focused our analysis upon I12b.
We next studied SVZ NSCs with and without acute
Jmjd3 deletion. During differentiation, H3K27me3 at I12b wasports 8, 1290–1299, September 11, 2014 ª2014 The Authors 1295
Figure 5. JMJD3 Is Required for the Activa-
tion of the I12b Enhancer
(A) The genomic region including Dlx2 and the I12b
enhancer (yellow). Arrow indicates the Dlx2 pro-
moter. A region 1 kb upstream of Dlx2 was also
analyzed.
(B) FACS plots of SVZ cell isolation.
(C–E) qChIP analysis of H3K27me3 (C), JMJD3 (D),
and H3K27ac (E) in FACS isolated GFAP+,
NESTIN+ cells and Tuj1+ cells. ***p < 0.001,
*p < 0.05.
(F and F0) qChIP analysis of H3K27me3 in control
(EtOH) and Jmjd3-deleted cells (4OHT) at the I12b
enhancer and Dlx2 promoter. White bars corre-
spond to control cells. Hatched bars correspond
to Jmjd3-deleted cells. **p < 0.01 compared to
proliferating control cells.
(G) qChIP analysis of JMJD3 at I12b and the Dlx2
promoter in differentiating NSCs. *p < 0.05 in
comparison to 1 kb upstream region.
(H) qChIP analysis of MLL1 at Dlx2 promoter and
I12b enhancer during NSC differentiation. **p <
0.01, *p < 0.05 compared to 1 kb upstream region.
(I) qChIP analysis of JMJD3 at I12b during dif-
ferentiation in control and Mll1-deleted cells.
**p < 0.01.
(J) qChIP analysis of MLL1 at I12b during differ-
entiation in control and Jmjd3-deleted cells.
**p < 0.01. Error bars represent SD; n = 3. undiff,
undifferentiated SVZ NSCs; +diff, differentiated
SVZ cells.decreased in control cells. In contrast, in Jmjd3-deleted cells,
H3K27me3 did not decrease at the I12b enhancer (Figures 5F
and 5F0), correlating with the lack of Dlx2 upregulation (Fig-
ure 3C). Furthermore, JMJD3 was enriched at I12b during
differentiation (Figure 5G). Thus, Jmjd3 is required for H3K27
demethylation at the I12b enhancer.
In differentiatingMll1-deficient SVZ cells, the Dlx2 locus is en-
riched with H3K27me3 and its transcription remains repressed
(Lim et al., 2009). We therefore investigated a potential molecu-
lar-genetic relationship betweenMll1 and Jmjd3 in the regulation
of Dlx2. In differentiating SVZ cells, MLL1 was localized at both
I12b and the Dlx2 promoter (Figure 5H). Interestingly, in Mll1-
deleted NSCs, JMJD3 was not enriched at I12b (Figure 5I) and
Dlx2 is not properly expressed. However, in Jmjd3-deleted cells,
MLL1 remained enriched at I12b (Figure 5J). Taken together,
these data indicate that Mll1 is required for the enrichment of
JMJD3 at I12b.1296 Cell Reports 8, 1290–1299, September 11, 2014 ª2014 The AuthorsDISCUSSION
Our study demonstrates that JMJD3 is
required for the lifelong neurogenesis of
SVZ NSCs and further illustrates mecha-
nisms by which JMJD3 activates neuro-
genic gene expression. In addition to
acting at gene promoters, JMJD3 also lo-
calizes to neural transcriptional enhancers
and regulates the chromatin state of the
I12b enhancer of Dlx2 (Figure S5F).While multiple studies have indicated the critical nature of
Polycomb-mediated transcriptional repression in neural devel-
opment (Hirabayashi and Gotoh, 2010; Hwang et al., 2014), the
role of active H3K27me3 demethylation has been less clear.
How do H3K27me3-repressed genes normally become acti-
vated? While loss of H3K27me3 at specific loci could potentially
be passive (e.g., through decreased EZH2 activity), EZH2 ex-
pression is not downregulated during SVZ neurogenesis (Hwang
et al., 2014). In this study, we show that active H3K27me3
demethylation via JMJD3 is required for efficient expression of
lineage-specific genes.
Without Jmjd3, SVZ NSCs appear to be ‘‘stalled’’ in a precur-
sor cell state. Jmjd3-deficient SVZ NSCs did not efficiently
activate Dlx2 expression and were defective for neurogenesis.
However, Jmjd3 did not appear to be required for NSC identity,
suggesting that Jmjd3 does not play a key role in SVZNSCmain-
tenance. Interestingly, adult hGFAP-Cre;Jmjd3F/F mice had
greater numbers of cells with type B1 cell characteristics. Given
that we did not observe increased cell proliferation with Jmjd3
deficiency, it is possible that the accumulation of type B1-like
cells in hGFAP-Cre;Jmjd3F/F mice relates to an increase in the
proportion of symmetric, self-renewing divisions, as compared
to asymmetric NSC divisions that lead to the generation of differ-
entiated cell types.
In the developing neocortex (Estara´s et al., 2012; Visel
et al., 2013), we found that 59% of the mapped enhancers
exhibited JMJD3 enrichment. Notably, these enhancers corre-
sponded strongly to neuron differentiation, forebrain develop-
ment, regulation of neurogenesis, and other activities consis-
tent with NSC differentiation and cortical development. These
data support a role for JMJD3 at neural enhancers genome-
wide in neural precursor cells, including those in the developing
brain.
The requirement of JMJD3 for H3K27me3 demethylation at
the I12b enhancer does not diminish the function of JMJD3 at
gene promoter regions. Indeed, JMJD3 enrichment has been
mapped to 7,170 promoter regions in NSCs cultured from
E12.5 cortex (Estara´s et al., 2012), and JMJD3-dependent
H3K27me3 demethylation occurs at a number of different neural
gene promoters (Akizu et al., 2010; Burgold et al., 2008; Iida
et al., 2014). In this study, we found that the promoter regions
of Myt1, Slc32a1, and Gjb6 required JMJD3 for H3K27me3 de-
methylation and transcriptional activation. Taken together, these
data suggest that JMJD3 acts at both promoters and enhancers
in NSC populations.
Although UTX (KDM6A)—the other known H3K27me3-
specific demethylase (Lan et al., 2007)—is required to activate
gene expression in the developing heart, Utx null ESCs can effi-
ciently differentiate into neurons, suggesting that UTX is not
necessary for neuronal differentiation per se (Lee et al., 2012).
In SVZ NSCs, Jmjd3 deficiency did not affect the expression of
Utx, indicating that Utx alone is not sufficient to activate Dlx2
expression, and RNAi knockdown of Utx in SVZ cells did not
inhibit neurogenesis (data not shown). Thus, different develop-
mental lineages may utilize UTX and JMJD3 in a nonredundant
manner.
How JMJD3 becomes localized at specific genomic regions is
not well known, but emerging evidence indicates that transcrip-
tion factors such as SMAD3 and HES1 are involved (Dai et al.,
2010; Estara´s et al., 2012). JMJD3 has also been found in tri-
thorax group (trxG) chromatin remodeling complexes (De Santa
et al., 2007), and trxG family member Mll1 is required for SVZ
neurogenesis (Lim et al., 2009). In SVZ cells, we found both
MLL1 and JMJD3 proteins localized at I12b, and JMJD3 enrich-
ment at this enhancer was lost inMll1-deleted cells. While these
data indicate that JMJD3 requires MLL1 for localization to a key
neurogenic enhancer, it remains to be determined whetherMLL1
and JMJD3 physically interact at I12b. Alternatively, MLL1 may
be required tomediate local chromatin modifications that enable
the subsequent recruitment of JMJD3 to specific genomic re-
gions. The discovery of this genetic interaction may provide in-
sights into howmutations in MLL genes and H3K27me3-specific
demethylases contribute to the transcriptional dysregulation of
medulloblastomas (Jones et al., 2012; Parsons et al., 2011).
Finally, our studies establish JMJD3 as a central player for theCell Reactivation of neurogenesis from a neural stem cell population,
which may help inform methods of neuronal production for ther-
apeutic purposes.
EXPERIMENTAL PROCEDURES
Generation of Jmjd3 Conditional Knockout Mice and Mouse Studies
Jmjd3F/F mice were generated, maintained, and genotyped as described
previously (Iwamori et al., 2013). BrdU (50 mg/g body weight, Sigma) or EdU
(102 mmol/g body weight, Invitrogen) was injected intraperitoneally. Stereo-
tactic SVZ injections were performed essentially as described previously (Mir-
zadeh et al., 2008). Briefly, for adult Jmjd3-deletion studies, we coinjected
100 nl of adenovirus (Ad:GFAP-Cre) and LV-GFP lentivirus. For Dlx2 overex-
pression, we coinjected 100 nl of LV-Dlx2-GFP and LV-AP-DsRed into the
SVZ. Stereotactic SVZ coordinates were 0.5 mm anterior, 1.3 mm lateral (rela-
tive to bregma), and 1.75mmdeep to the pia. Brains were fixed by intracardiac
perfusion and sectioned on a cryostat (Leica) at 12 or 16 mm thickness. After
blocking, primary antibodies were incubated at 4C overnight. Antibody dilu-
tions are listed in the Supplemental Experimental Procedures. Whole-mount
dissection and immunostaining was performed as described elsewhere (Mir-
zadeh et al., 2008). From each animal, we analyzed at least three separate
tissue sections, and from each section, we collectedmore than three nonover-
lapping confocal images (Leica TCS SP5X) with 203 or 633 oil objectives for
quantification (ImageJ, NIH). Experiments were performed in accordance to
protocols approved by Institutional Animal Care and Use Committee at
University of California, San Francisco.
Cell-Culture Studies
SVZ NSC monolayer cultures were generated and analyzed as in Lim et al.
(2009). High-titer pSicoR lentiviruses were produced in human embryonic
kidney 293T cells as described previously (Lewis et al., 2001). For Jmjd3
knockdown, we derived SVZ NSCs from transgenic mice that express the
tva receptor under the control of the GFAP promoter (GFAPp-tva) (Holland
et al., 1998). To delete Jmjd3 in SVZ NSCs, cultures from UBC-Cre/
ERT2;Jmjd3F/F mice were treated with 4-OHT (50 nM, Sigma) for 96 hr. For
RA treatment and Jmjd3 overexpression, SVZ NSC monolayer cultures
were established as described previously (Brill et al., 2008). For Jmjd3 over-
expression, pCDNA-Flag Jmjd3 and pCDNA-Flag Jmjd3 mutant (H1388/A)
(Burgold et al., 2008) were transfected using jetPRIME (Polyplus) and
analyzed after 48 hr. For each culture well, we captured more than 13
nonoverlapping fields (Leica DMI4000B) with a 203 objective and analyzed
them with ImageJ (NIH). Primary and secondary antibodies are listed in the
Supplemental Experimental Procedures. SYTOX red (Invitrogen) was used
per the manufacturer’s protocol and quantified on a fluorescent flow cytom-
eter (BD FACSAria).
ChIP, qRT-PCR, Microarray, and Bioinformatic Analysis
Quantitative ChIP (qChIP) and quantitative RT-PCR was performed essen-
tially as previously described (Lim et al., 2009). qChIP analysis of FACS-
isolated cells was performed as described previously (Hwang et al., 2014).
ChIP antibodies and primer sequences and other methodological details
are in the Supplemental Experimental Procedures and Table S1. For micro-
array analysis, biological replicates were prepared as in (Ramos et al., 2013)
and hybridized to MouseRef-8 v2.0 Expression BeadChip arrays (Illumina).
Array data were normalized with IlluminaNormalizer v.2 and analyzed with
Cyber-T (http://cybert.ics.uci.edu/). Gene Ontology analysis was performed
with DAVID. SVZ RNA-seq and SVZ NSC ChIP-seq data were analyzed as
in Ramos et al. (2013). ChIP-seq data from Gene Expression Omnibus
(GEO) series GSE36673, GSE42881, and GSE13845 were analyzed as fol-
lows: FASTQ reads were aligned to mm9 using Bowtie2 2.1.0 with default
parameters. Tracks and peaks were generated using MACS 1.4 with default
parameters. Co-occupancy analysis was performed using BEDTools against
published peaks. Genomic Regions Enrichment of Annotations Tool (GREAT)
analysis was performed as described previously (McLean et al., 2010). Anal-
ysis parameters and references are in the Supplemental Experimental
Procedures.ports 8, 1290–1299, September 11, 2014 ª2014 The Authors 1297
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